BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On March7, 2017 Directors Louis Drapeau, Robert Malchione, Joel
McComb and Deborah Neff provided notice to Chairman of the Board,
President and CEO Norman Schwartz that they are declining to
stand for reelection to the Board of Directors at the 2017 Annual
Meeting due to disagreements with the management of the Company
regarding executive personnel and corporate governance matters.
Messrs. Drapeau and Malchione and Ms.Neff serve as members of the
Audit Committee and Mr.Drapeau and Ms.Neff serve as members of
the Compensation Committee.
|ITEM9.01||Financial Statements and Exhibits.|
|17.1||Notice of Intention Not to Stand for Reelection|
About BIO-RAD LABORATORIES, INC. (NYSE:BIO)
Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world. BIO-RAD LABORATORIES, INC. (NYSE:BIO) Recent Trading Information
BIO-RAD LABORATORIES, INC. (NYSE:BIO) closed its last trading session down -0.03 at 197.25 with 317,845 shares trading hands.